Antiviral strategies to control calicivirus infections

Antiviral Research

Volumn 87, Issue 2, 2010, Pages 162-178

  Rohayem, Jacques ^a   Bergmann, Mirko ^a   Gebhardt, Julia ^a   Gould, Ernest ^b,c   Tucker, Paul ^d   Mattevi, Andrea ^e   Unge, Torsten ^f   Hilgenfeld, Rolf ^g   Neyts, Johan ^h  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^e UNIVERSITY OF PAVIA   (Italy)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY OF LÜBECK   (Germany)

^h REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral therapy; Calicivirus; Viral enzymes; VIZIER

Indexed keywords

ANTIVIRUS AGENT; CHYMOTRYPSIN; FUCOSYLTRANSFERASE; RNA DIRECTED RNA POLYMERASE; VIRUS RNA; ENZYME; VIRUS PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; CALICIVIRUS INFECTION; CLINICAL FEATURE; DRUG DESIGN; HOST CELL; HOST RESISTANCE; IMMUNITY; INFECTION CONTROL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPTOM; VETERINARY MEDICINE; VIRION; VIROLOGY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; CALICIVIRIDAE INFECTIONS; CALICIVIRUS; CHEMISTRY; DRUG EFFECTS; EPIDEMIC; EUROPE; EUROPEAN UNION; GENETICS; HUMAN; MEDICAL RESEARCH; METABOLISM; ORGANIZATION AND MANAGEMENT; TRENDS; UNITED STATES; VETERINARY;

ANIMALS; ANTIVIRAL AGENTS; BIOMEDICAL RESEARCH; CALICIVIRIDAE; CALICIVIRIDAE INFECTIONS; DISEASE OUTBREAKS; DRUG DESIGN; ENZYMES; EUROPE; EUROPEAN UNION; HUMANS; UNITED STATES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

CALICIVIRIDAE; NOROVIRUS; ORYCTOLAGUS CUNICULUS; RABBIT HEMORRHAGIC DISEASE VIRUS;

EID: 77954952691     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.05.002     Document Type: Review

References (247)

1. Allaire M., Chernaia M.M., Malcolm B.A., James M.N. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 1994, 369:72-76.
2. Anand K., Palm G.J., Mesters J.R., Siddell S.G., Ziebuhr J., Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. Embo J. 2002, 21:3213-3224.
3. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300:1763-1767.
4. Anderson E.J. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev. Anti Infect. Ther. 2010, 8:205-217.
5. Asanaka M., Atmar R.L., Ruvolo V., Crawford S.E., Neill F.H., Estes M.K. Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2005.
6. Atmar R.L., Opekun A.R., Gilger M.A., Estes M.K., Crawford S.E., Neill F.H., Graham D.Y. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 2008, 14:1553-1557.
7. Bailey D., Karakasiliotis I., Vashist S., Chung L.M., Reese J., McFadden N., Benson A., Yarovinsky F., Simmonds P., Goodfellow I. Functional analysis of RNA structures present at the 3' extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence. J. Virol. 2010, 84:2859-2870.
8. Bailey D., Kaiser W.J., Hollinshead M., Moffat K., Chaudhry Y., Wileman T., Sosnovtsev S.V., Goodfellow I.G. Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation. J. Gen. Virol. 2010, 91:739-749.
9. Bailey D., Thackray L.B., Goodfellow I.G. A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J. Virol. 2008, 82:7725-7728.
10. Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., Estes M.K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J. Virol. 1998, 72:1345-1353.
11. Belliot G., Sosnovtsev S.V., Chang K.O., McPhie P., Green K.Y. Nucleotidylylation of the VPg protein of a human norovirus by its proteinase-polymerase precursor protein. Virology 2008, 374:33-49.
12. Belliot G., Sosnovtsev S.V., Mitra T., Hammer C., Garfield M., Green K.Y. In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells. J. Virol. 2003, 77:10957-10974.
13. Bergmann E.M., Mosimann S.C., Chernaia M.M., Malcolm B.A., James M.N. The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J. Virol. 1997, 71:2436-2448.
14. Bhella D., Gatherer D., Chaudhry Y., Pink R., Goodfellow I.G. Structural insights into calicivirus attachment and uncoating. J. Virol. 2008, 82:8051-8058.
15. Biswal B.K., Cherney M.M., Wang M., Chan L., Yannopoulos C.G., Bilimoria D., Nicolas O., Bedard J., James M.N.G. Crystal structures of the RNA dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J. Biol. Chem. 2005, 280:18202-18210.
16. Bitko V., Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 2001, 1:34.
17. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 2005, 11:50-55.
18. Boden D., Pusch O., Lee F., Tucker L., Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 2003, 77:11531-11535.
19. Bok K., Cavanaugh V.J., Matson D.O., Gonzalez-Molleda L., Chang K.O., Zintz C., Smith A.W., Iversen P., Green K.Y., Campbell A.E. Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome. Virology 2008, 380:328-337.
20. Bordeleau M.E., Cencic R., Lindqvist L., Oberer M., Northcote P., Wagner G., Pelletier J. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem. Biol. 2006, 13:1287-1295.
21. Boussadia O., Niepmann M., Creancier L., Prats A.C., Dautry F., Jacquemin-Sablon H. Unr is required in vivo for efficient initiation of translation from the internal ribosome entry sites of both rhinovirus and poliovirus. J. Virol. 2003, 77:3353-3359.
22. Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., Zhang X.C., Jiang X., Li X., Rao Z. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 2007, 81:5949-5957.
23. Capucci L., Fusi P., Lavazza A., Pacciarini M.L., Rossi C. Detection and preliminary characterization of a new rabbit calicivirus related to rabbit hemorrhagic disease virus but nonpathogenic. J. Virol. 1996, 70:8614-8623.
24. Chakravarty S., Hutson A.M., Estes M.K., Prasad B.V. Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J. Virol. 2005, 79:554-568.
25. Chang K.O., George D.W. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J. Virol. 2007, 81:12111-12118.
26. Chang K.O., Kim Y., Green K.Y., Saif L.J. Cell-culture propagation of porcine enteric calicivirus mediated by intestinal contents is dependent on the cyclic AMP signaling pathway. Virology 2002, 304:302-310.
27. Chang K.O., Sosnovtsev S.V., Belliot G., Kim Y., Saif L.J., Green K.Y. Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8733-8738.
28. Chang K.O., Sosnovtsev S.V., Belliot G., King A.D., Green K.Y. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 2006.
29. Changotra H., Jia Y., Moore T.N., Liu G., Kahan S.M., Sosnovtsev S.V., Karst S.M. Type I and type II interferons inhibit the translation of murine norovirus proteins. J. Virol. 2009, 83:5683-5692.
30. Chaudhry Y., Skinner M.A., Goodfellow I.G. Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J. Gen. Virol. 2007, 88:2091-2100.
31. Chen R., Neill J.D., Estes M.K., Prasad B.V. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8048-8053.
32. Chen R., Neill J.D., Noel J.S., Hutson A.M., Glass R.I., Estes M.K., Prasad B.V. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol. 2004, 78:6469-6479.
33. Choi K.H., Groarke J.M., Young D.C., Kuhn R.J., Smith J.L., Pevear D.C., Rossmann M.G. The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4425-4430.
34. Clarke I.N., Lambden P.R. Organization and expression of calicivirus genes. J. Infect. Dis. 2000, 181(Suppl. 2):S309-S316.
35. Coyne K.P., Jones B.R., Kipar A., Chantrey J., Porter C.J., Barber P.J., Dawson S., Gaskell R.M., Radford A.D. Lethal outbreak of disease associated with feline calicivirus infection in cats. Vet. Rec. 2006, 158:544-550.
36. Cox C., Cao S., Lu Y. Enhanced detection and study of murine norovirus-1 using a more efficient microglial cell line. Virol. J. 2009, 6:196.
37. Crisci E., Almanza H., Mena I., Cordoba L., Gomez-Casado E., Caston J.R., Fraile L., Barcena J., Montoya M. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant. Virology 2009, 387:303-312.
38. Daughenbaugh K.F., Fraser C.S., Hershey J.W., Hardy M.E. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. Embo J. 2003, 22:2852-2859.
39. Daughenbaugh K.F., Wobus C.E., Hardy M.E. VPg of murine norovirus binds translation initiation factors in infected cells. Virol. J. 2006, 3:33.
40. Di Martino B., Marsilio F., Roy P. Assembly of feline calicivirus-like particle and its immunogenicity. Vet. Microbiol. 2007, 120:173-178.
41. Ettayebi K., Hardy M.E. Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein. J. Virol. 2003, 77:11790-11797.
42. Farkas T., Dufour J., Jiang X., Sestak K. Detection of norovirus-, sapovirus- and rhesus enteric calicivirus-specific antibodies in captive juvenile macaques. J. Gen. Virol. 2010, 91:734-738.
43. Farkas T., Sestak K., Wei C., Jiang X. Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae. J. Virol. 2008, 82:5408-5416.
44. Farkas T., Zhong W.M., Jing Y., Huang P.W., Espinosa S.M., Martinez N., Morrow A.L., Ruiz-Palacios G.M., Pickering L.K., Jiang X. Genetic diversity among sapoviruses. Arch. Virol. 2004, 149:1309-1323.
45. Virus Taxonomy, VIIIth Report of the International Committee on Taxonomy of Viruses 2005, Elsevier/Academic Press, London. C.M. Fauquet, M.A. Mayo, J. Manioloff, U. Desselberger, L.A. Ball (Eds.).
46. Feng X., Jiang X. Library screen for inhibitors targeting norovirus binding to histo-blood group antigen receptors. Antimicrob. Agents Chemother. 2007, 51:324-331.
47. Ferrer-Orta C., Arias A., Perez-Luque R., Escarmis C., Domingo E., Verdaguer N. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J. Biol. Chem. 2004, 279:47212-47221.
48. Foley J., Hurley K., Pesavento P.A., Poland A., Pedersen N.C. Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants. J. Feline Med. Surg. 2006, 8:55-61.
49. Forrester N.L., Boag B., Moss S.R., Turner S.L., Trout R.C., White P.J., Hudson P.J., Gould E.A. Long-term survival of New Zealand rabbit haemorrhagic disease virus RNA in wild rabbits, revealed by RT-PCR and phylogenetic analysis. J. Gen. Virol. 2003, 84:3079-3086.
50. Forrester N.L., Trout R.C., Gould E.A. Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire. Virology 2007, 358:18-22.
51. Fullerton S.W., Blaschke M., Coutard B., Gebhardt J., Gorbalenya A., Canard B., Tucker P.A., Rohayem J. Structural and functional characterization of sapovirus RNA-dependent RNA polymerase. J. Virol. 2007, 81:1858-1871.
52. Gabriel G., Nordmann A., Stein D.A., Iversen P.L., Klenk H.D. Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J. Gen. Virol. 2008, 89:939-948.
53. Gallimore C.I., Green J., Lewis D., Richards A.F., Lopman B.A., Hale A.D., Eglin R., Gray J.J., Brown D.W. Diversity of noroviruses cocirculating in the north of England from 1998 to 2001. J. Clin. Microbiol. 2004, 42:1396-1401.
54. Gallimore C.I., Iturriza-Gomara M., Lewis D., Cubitt D., Cotterill H., Gray J.J. Characterization of sapoviruses collected in the United Kingdom from 1989 to 2004. J. Med. Virol. 2006, 78:673-682.
55. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8676-8681.
56. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2718-2723.
57. Gerondopoulos A., Jackson T., Monaghan P., Doyle N., Roberts L.O. Murine norovirus-1 cell entry is mediated through a non-clathrin, non-caveolae, dynamin and cholesterol dependent pathway. J. Gen. Virol. 2010, (Epub Feb 10).
58. Ghetti A., Pinol-Roma S., Michael W.M., Morandi C., Dreyfuss G. hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 1992, 20:3671-3678.
59. Gibson T., Higgins D., Thompson J. ClustalX, Heidelberg: EMBL, Cork: UCC 1999, IGBMC, Strasbourg.
60. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 1999, 68:913-963.
61. Goodfellow I., Chaudhry Y., Gioldasi I., Gerondopoulos A., Natoni A., Labrie L., Laliberte J.F., Roberts L. Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO Rep. 2005, 6:968-972.
62. Goodfellow I., Chaudhry Y., Richardson A., Meredith J., Almond J.W., Barclay W., Evans D.J. Identification of a cis-acting replication element within the poliovirus coding region. J. Virol. 2000, 74:4590-4600.
63. Goodfellow I.G., Kerrigan D., Evans D.J. Structure and function analysis of the poliovirus cis-acting replication element (CRE). RNA 2003, 9:124-137.
64. Gray J. Assays for virus infection. Virus Culture: A Practical Approach 1999, Oxford University Press, Oxford. J. Cahn (Ed.).
65. Green K.Y. Caliciviridae: the noroviruses. Fields Virology 2007, Lippincott Williams and Wilkins. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
66. Green K.Y., Ando T., Balayan M.S., Berke T., Clarke I.N., Estes M.K., Matson D.O., Nakata S., Neill J.D., Studdert M.J., Thiel H.J. Taxonomy of the caliciviruses. J. Infect. Dis. 2000, 181(Suppl. 2):S322-S330.
67. Green K.Y., Chanock R.M., Kapikian A.Z. Human caliciviruses. Fields Virology 2001, Lippincott Williams and Wilkins. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
68. Green K.Y., Kapikian A.Z., Valdesuso J., Sosnovtsev S., Treanor J.J., Lew J.F. Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus. J. Clin. Microbiol. 1997, 35:1909-1914.
69. Green K.Y., Lew J.F., Jiang X., Kapikian A.Z., Estes M.K. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 1993, 31:2185-2191.
70. Gritsun T.S., Gould E.A. The 3' untranslated region of tick-borne flaviviruses originated by the duplication of long repeat sequences within the open reading frame. Virology 2006, 354:217-223.
71. Gritsun T.S., Gould E.A. The 3' untranslated regions of Kamiti River virus and cell fusing agent virus originated by self-duplication. J. Gen. Virol. 2006, 87:2615-2619.
72. Gritsun T.S., Gould E.A. Direct repeats in the flavivirus 3' untranslated region; a strategy for survival in the environment?. Virology 2007, 358:258-265.
73. Guerrero R.A., Ball J.M., Krater S.S., Pacheco S.E., Clements J.D., Estes M.K. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 2001, 75:9713-9722.
74. Guo M., Evermann J.F., Saif L.J. Detection and molecular characterization of cultivable caliciviruses from clinically normal mink and enteric caliciviruses associated with diarrhea in mink. Arch. Virol. 2001, 146:479-493.
75. Guo M., Qian Y., Chang K.O., Saif L.J. Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine. J. Clin. Microbiol. 2001, 39:1487-1493.
76. Gutierrez-Escolano A.L., Vazquez-Ochoa M., Escobar-Herrera J., Hernandez-Acosta J. La, PTB, and PAB proteins bind to the 3(') untranslated region of Norwalk virus genomic RNA. Biochem. Biophys. Res. Commun. 2003, 311:759-766.
77. Haasnoot J., Westerhout E.M., Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 2007, 25:1435-1443.
78. Haasnoot P.C., Olsthoorn R.C., Bol J.F. The Brome mosaic virus subgenomic promoter hairpin is structurally similar to the iron-responsive element and functionally equivalent to the minus-strand core promoter stem-loop C. RNA 2002, 8:110-122.
79. Hansman G.S., Katayama K., Oka T., Natori K., Takeda N. Mutational study of sapovirus expression in insect cells. Virol. J. 2005, 2:13.
80. Hansman G.S., Oka T., Katayama K., Takeda N. Enhancement of sapovirus recombinant capsid protein expression in insect cells. FEBS Lett. 2006, 580:4047-4050.
81. Hansman G.S., Oka T., Katayama K., Takeda N. Human sapoviruses: genetic diversity, recombination, and classification. Rev. Med. Virol. 2007, 17:133-141.
82. Hansman G.S., Takeda N., Oka T., Oseto M., Hedlund K.O., Katayama K. Intergenogroup recombination in sapoviruses. Emerg. Infect. Dis. 2005, 11:1916-1920.
83. Henderson K.S. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab. Anim. (NY) 2008, 37:314-320.
84. Hennessy E.P., Green A.D., Connor M.P., Darby R., MacDonald P. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 2003, 188:176-177.
85. Herschlag D. RNA chaperones and the RNA folding problem. J. Biol. Chem. 1995, 270:20871-20874.
86. Hogbom M., Jager K., Robel I., Unge T., Rohayem J. The active form of the norovirus RNA-dependent RNA polymerase is a homodimer with cooperative activity. J. Gen. Virol. 2009, 90:281-291.
87. Hsu C.C., Riley L.K., Livingston R.S. Molecular characterization of three novel murine noroviruses. Virus Genes 2007, 34:147-155.
88. Huang C., Hess J., Gill M., Hustead D. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease. J. Feline Med. Surg. 2010, 12:129-137.
89. Huang P., Morrow A.L., Jiang X. The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition. Glycoconj. J. 2009, 26:1085-1096.
90. Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow A.L., Altaye M., Pickering L.K., Newburg D.S., LePendu J., Jiang X. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 2003, 188:19-31.
91. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., Jiang X. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 2005, 79:6714-6722.
92. Huang P., Lai M.M. Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J. Virol. 2001, 75:5009-5017.
93. Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., Mason H.S. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005, 23:1851-1858.
94. Humphrey T.J., Cruickshank J.G., Cubitt W.D. An outbreak of calicivirus associated gastroenteritis in an elderly persons home. A possible zoonosis?. J. Hyg. (Lond.) 1984, 93:293-299.
95. Hurley K.E., Pesavento P.A., Pedersen N.C., Poland A.M., Wilson E., Foley J.E. An outbreak of virulent systemic feline calicivirus disease. J. Am. Vet. Med. Assoc. 2004, 224:241-249.
96. Hutson A.M., Atmar R.L., Graham D.Y., Estes M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 2002, 185:1335-1337.
97. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 2003, 21:635-637.
98. Jiang X., Espul C., Zhong W.M., Cuello H., Matson D.O. Characterization of a novel human calicivirus that may be a naturally occurring recombinant. Arch. Virol. 1999, 144:2377-2387.
99. Jiang X., Wang M., Graham D.Y., Estes M.K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 1992, 66:6527-6532.
100. Jiang X., Zhong W., Kaplan M., Pickering L.K., Matson D.O. Expression and characterization of Sapporo-like human calicivirus capsid proteins in baculovirus. J. Virol. Methods 1999, 78:81-91.
101. Johansson P.J., Bergentoft K., Larsson P.A., Magnusson G., Widell A., Thorhagen M., Hedlund K.O. A nosocomial sapovirus-associated outbreak of gastroenteritis in adults. Scand. J. Infect. Dis. 2005, 37:200-204.
102. Kaiser W.J., Chaudhry Y., Sosnovtsev S.V., Goodfellow I.G. Analysis of protein-protein interactions in the feline calicivirus replication complex. J. Gen. Virol. 2006, 87:363-368.
103. Kapp L.D., Lorsch J.R. The molecular mechanics of eukaryotic translation. Annu. Rev. Biochem. 2004, 73:657-704.
104. Karakasiliotis I., Chaudhry Y., Roberts L.O., Goodfellow I.G. Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent. J. Gen. Virol. 2006, 87:3339-3347.
105. Karst S.M., Wobus C.E., Lay M., Davidson J., Virgin H.W.t. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003, 299:1575-1578.
106. Katayama H., Okuma K., Furumai H., Ohgaki S. Series of surveys for enteric viruses and indicator organisms in Tokyo Bay after an event of combined sewer overflow. Water Sci. Technol. 2004, 50:259-262.
107. Keswick B.H., Satterwhite T.K., Johnson P.C., DuPont H.L., Secor S.L., Bitsura J.A., Gary G.W., Hoff J.C. Inactivation of Norwalk virus in drinking water by chlorine. Appl. Environ. Microbiol. 1985, 50:261-264.
108. Kirkwood C.D., Streitberg R. Calicivirus shedding in children after recovery from diarrhoeal disease. J. Clin. Virol. 2008, 43:346-348.
109. Koopmans M. Outbreaks of viral gastroenteritis: what's new in 2004?. Curr. Opin. Infect. Dis. 2005, 18:295-299.
110. Koopmans M., Duizer E. Foodborne viruses: an emerging problem. Int. J. Food Microbiol. 2004, 90:23-41.
111. Koopmans M., von Bonsdorff C.H., Vinje J., de Medici D., Monroe S. Foodborne viruses. FEMS Microbiol. Rev. 2002, 26:187-205.
112. Laurent S., Vautherot J.F., Le Gall G., Madelaine M.F., Rasschaert D. Structural, antigenic and immunogenic relationships between European brown hare syndrome virus and rabbit haemorrhagic disease virus. J. Gen. Virol. 1997, 78(Pt 11):2803-2811.
113. Li C.X., Parker A., Menocal E., Xiang S., Borodyansky L., Fruehauf J.H. Delivery of RNA interference. Cell Cycle 2006, 5:2103-2109.
114. Lin C.H., Patton J.G. Regulation of alternative 3' splice site selection by constitutive splicing factors. RNA 1995, 1:234-245.
115. Lin X., Ruan X., Anderson M.G., McDowell J.A., Kroeger P.E., Fesik S.W., Shen Y. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res. 2005, 33:4527-4535.
116. Lindesmith L., Moe C., Lependu J., Frelinger J.A., Treanor J., Baric R.S. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 2005, 79:2900-2909.
117. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003, 9:548-553.
118. Lindqvist R., Andersson Y., Lindback J., Wegscheider M., Eriksson Y., Tidestrom L., Lagerqvist-Widh A., Hedlund K.O., Lofdahl S., Svensson L., Norinder A. A one-year study of foodborne illnesses in the municipality of Uppsala, Sweden. Emerg. Infect. Dis. 2001, 7:588-592.
119. Liu G., Kahan S.M., Jia Y., Karst S.M. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. J. Virol. 2009, 83:6963-6968.
120. Liu B.L., Viljoen G.J., Clarke I.N., Lambden P.R. Identification of further proteolytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli. J. Gen. Virol. 1999, 80(Pt 2):291-296.
121. LoBue A.D., Lindesmith L., Yount B., Harrington P.R., Thompson J.M., Johnston R.E., Moe C.L., Baric R.S. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006, 24:5220-5234.
122. Lopman B.A., Brown D.W., Koopmans M. Human caliciviruses in Europe. J. Clin. Virol. 2002, 24:137-160.
123. Low W.K., Dang Y., Schneider-Poetsch T., Shi Z., Choi N.S., Merrick W.C., Romo D., Liu J.O. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol. Cell 2005, 20:709-722.
124. Lupfer C., Stein D.A., Mourich D.V., Tepper S.E., Iversen P.L., Pastey M. Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers. Arch. Virol. 2008, 153:929-937.
125. Luttermann C., Meyers G. A bipartite sequence motif induces translation reinitiation in feline calicivirus RNA. J. Biol. Chem. 2007, 282:7056-7065.
126. Lynch M., Painter J., Woodruff R., Braden C. Surveillance for foodborne-disease outbreaks-United States, 1998-2002. MMWR Surveill. Summ. 2006, 55:1-42.
127. Machin A., Martin Alonso J.M., Parra F. Identification of the amino acid residue involved in rabbit hemorrhagic disease virus VPg uridylylation. J. Biol. Chem. 2001, 276:27787-27792.
128. Makino A., Shimojima M., Miyazawa T., Kato K., Tohya Y., Akashi H. Junctional adhesion molecule 1 is a functional receptor for feline calicivirus. J. Virol. 2006, 80:4482-4490.
129. Marionneau S., Cailleau-Thomas A., Rocher J., Le Moullac-Vaidye B., Ruvoen N., Clement M., Le Pendu J. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001, 83:565-573.
130. Marionneau S., Ruvoen N., Le Moullac-Vaidye B., Clement M., Cailleau-Thomas A., Ruiz-Palacois G., Huang P., Jiang X., Le Pendu J. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122:1967-1977.
131. Martella V., Campolo M., Lorusso E., Cavicchio P., Camero M., Bellacicco A.L., Decaro N., Elia G., Greco G., Corrente M., Desario C., Arista S., Banyai K., Koopmans M., Buonavoglia C. Norovirus in captive lion cub (Panthera leo). Emerg. Infect. Dis. 2007, 13:1071-1073.
132. Martella V., Lorusso E., Decaro N., Elia G., Radogna A., D'Abramo M., Desario C., Cavalli A., Corrente M., Camero M., Germinario C.A., Banyai K., Di Martino B., Marsilio F., Carmichael L.E., Buonavoglia C. Detection and molecular characterization of a canine norovirus. Emerg. Infect. Dis. 2008, 14:1306-1308.
133. Matson D.O., Berke T., Dinulos M.B., Poet E., Zhong W.M., Dai X.M., Jiang X., Golding B., Smith A.W. Partial characterization of the genome of nine animal caliciviruses. Arch. Virol. 1996, 141:2443-2456.
134. Matson D.O., Estes M.K., Glass R.I., Bartlett A.V., Penaranda M., Calomeni E., Tanaka T., Nakata S., Chiba S. Human calicivirus-associated diarrhea in children attending day care centers. J. Infect. Dis. 1989, 159:71-78.
135. Matsuura Y., Tohya Y., Onuma M., Roerink F., Mochizuki M., Sugimura T. Expression and processing of the canine calicivirus capsid precursor. J. Gen. Virol. 2000, 81:195-199.
136. Matthews D.A., Smith W.W., Ferre R.A., Condon B., Budahazi G., Sisson W., Villafranca J.E., Janson C.A., McElroy H.E., Gribskov C.L., et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 1994, 77:761-771.
137. Mauroy A., Scipioni A., Mathijs E., Miry C., Ziant D., Thys C., Thiry E. Noroviruses and sapoviruses in pigs in Belgium. Arch. Virol. 2008, 153:1927-1931.
138. Mayo M.A. A summary of taxonomic changes recently approved by ICTV. Arch. Virol. 2002, 147:1655-1663.
139. McCartney S.A., Thackray L.B., Gitlin L., Gilfillan S., Virgin Iv H.W., Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog. 2008, 4:e1000108.
140. Meerovitch K., Svitkin Y.V., Lee H.S., Lejbkowicz F., Kenan D.J., Chan E.K., Agol V.I., Keene J.D., Sonenberg N. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 1993, 67:3798-3807.
141. Mitra T., Sosnovtsev S.V., Green K.Y. Mutagenesis of tyrosine 24 in the VPg protein is lethal for feline calicivirus. J. Virol. 2004, 78:4931-4935.
142. Mosimann S.C., Cherney M.M., Sia S., Plotch S., James M.N. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 1997, 273:1032-1047.
143. Moss S.R., Turner S.L., Trout R.C., White P.J., Hudson P.J., Desai A., Armesto M., Forrester N.L., Gould E.A. Molecular epidemiology of Rabbit haemorrhagic disease virus. J. Gen. Virol. 2002, 83:2461-2467.
144. Muller B., Klemm U., Mas Marques A., Schreier E. Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch. Virol. 2007, 152:1709-1719.
145. Mumphrey S.M., Changotra H., Moore T.N., Heimann-Nichols E.R., Wobus C.E., Reilly M.J., Moghadamfalahi M., Shukla D., Karst S.M. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 2007, 81:3251-3263.
146. Murata T., Katsushima N., Mizuta K., Muraki Y., Hongo S., Matsuzaki Y. Prolonged norovirus shedding in infants
147. Nakamura K., Someya Y., Kumasaka T., Ueno G., Yamamoto M., Sato T., Takeda N., Miyamura T., Tanaka N. A norovirus protease structure provides insights into active and substrate binding site integrity. J. Virol. 2005, 79:13685-13693.
148. Nakata S., Chiba S., Terashima H., Nakao T. Prevalence of antibody to human calicivirus in Japan and Southeast Asia determined by radioimmunoassay. J. Clin. Microbiol. 1985, 22:519-521.
149. Napthine, S., Lever, R.A., Powell, M.L., Jackson, R.J., Brown, T.D., Brierley, I., 2009. Expression of the VP2 protein of murine norovirus by a translation termination-reinitiation strategy. PLoS One 4 (Epub Dec 22).
150. Neill J.D., Meyer R.F., Seal B.S. The capsid protein of vesicular exanthema of swine virus serotype A48: relationship to the capsid protein of other animal caliciviruses. Virus Res. 1998, 54:39-50.
151. Ng K.K., Cherney M.M., Vazquez A.L., Machin A., Alonso J.M., Parra F., James M.N. Crystal structures of active and inactive conformations of a caliciviral RNA-dependent RNA polymerase. J. Biol. Chem. 2002, 277:1381-1387.
152. Ng K.K., Pendas-Franco N., Rojo J., Boga J.A., Machin A., Alonso J.M., Parra F. Crystal structure of norwalk virus polymerase reveals the carboxyl terminus in the active site cleft. J. Biol. Chem. 2004, 279:16638-16645.
153. Numata K., Hardy M.E., Nakata S., Chiba S., Estes M.K. Molecular characterization of morphologically typical human calicivirus Sapporo. Arch. Virol. 1997, 142:1537-1552.
154. Oka T., Hansman G.S., Katayama K., Ogawa S., Nagata N., Miyamura T., Takeda N. Expression of sapovirus virus-like particles in mammalian cells. Arch. Virol. 2006, 151:399-404.
155. Oka T., Katayama K., Ogawa S., Hansman G.S., Kageyama T., Miyamura T., Takeda N. Cleavage activity of the sapovirus 3C-like protease in Escherichia coli. Arch. Virol. 2005, 150:2539-2548.
156. Oka T., Katayama K., Ogawa S., Hansman G.S., Kageyama T., Ushijima H., Miyamura T., Takeda N. Proteolytic processing of sapovirus ORF1 polyprotein. J. Virol. 2005, 79:7283-7290.
157. Oliver S.L., Asobayire E., Charpilienne A., Cohen J., Bridger J.C. Complete genomic characterization and antigenic relatedness of genogroup III, genotype 2 bovine noroviruses. Arch. Virol. 2007, 152:257-272.
158. Oliver S.L., Asobayire E., Dastjerdi A.M., Bridger J.C. Genomic characterization of the unclassified bovine enteric virus Newbury agent-1 (Newbury1) endorses a new genus in the family Caliciviridae. Virology 2006, 350:240-250.
159. Oliver S.L., Dastjerdi A.M., Wong S., El-Attar L., Gallimore C., Brown D.W., Green J., Bridger J.C. Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J. Virol. 2003, 77:2789-2798.
160. Oliver S.L., Wood E., Asobayire E., Wathes D.C., Brickell J.S., Elschner M., Otto P., Lambden P.R., Clarke I.N., Bridger J.C. Serotype 1 and 2 bovine noroviruses are endemic in cattle in the United kingdom and Germany. J. Clin. Microbiol. 2007, 45:3050-3052.
161. Oxford J., Kelly L., Davies S., Lambkin R. Antiviral testing. Virus Culture: A Practical Approach 1999, Oxford University Press, Oxford. J. Cahn (Ed.).
162. Paessler S., Rijnbrand R., Stein D.A., Ni H., Yun N.E., Dziuba N., Borisevich V., Seregin A., Ma Y., Blouch R., Iversen P.L., Zacks M.A. Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology 2008, 376:357-370.
163. Park S.I., Jeong C., Kim H.H., Park S.H., Park S.J., Hyun B.H., Yang D.K., Kim S.K., Kang M.I., Cho K.O. Molecular epidemiology of bovine noroviruses in South Korea. Vet. Microbiol. 2007, 124:125-133.
164. Park S.I., Jeong C., Park S.J., Kim H.H., Jeong Y.J., Hyun B.H., Chun Y.H., Kang M.I., Cho K.O. Molecular detection and characterization of unclassified bovine enteric caliciviruses in South Korea. Vet. Microbiol. 2008, 130:371-379.
165. Parrino T.A., Schreiber D.S., Trier J.S., Kapikian A.Z., Blacklow N.R. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 1977, 297:86-89.
166. Parsley T.B., Towner J.S., Blyn L.B., Ehrenfeld E., Semler B.L. Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 1997, 3:1124-1134.
167. Pedersen N.C., Elliott J.B., Glasgow A., Poland A., Keel K. An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus. Vet. Microbiol. 2000, 73:281-300.
168. Pelkmans L., Helenius A. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 2003, 15:414-422.
169. Pelletier J., Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334:320-325.
170. Pfister T., Wimmer E. Polypeptide p41 of a Norwalk-like virus is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 2001, 75:1611-1619.
171. Phan T.G., Okitsu S., Muller W.E., Kohno H., Ushijima H. Novel recombinant sapovirus, Japan. Emerg. Infect. Dis. 2006, 12:865-867.
172. Povey R.C. Effect of orally administered ribavirin on experimental feline calicivirus infection in cats. Am. J. Vet. Res. 1978, 39:1337-1341.
173. Povey R.C. In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus. Am. J. Vet. Res. 1978, 39:175-178.
174. Pöyry T.A., Kaminski A., Connell E.J., Fraser C.S., Jackson R.J. The mechanism of an exceptional case of reinitiation after translation of a long ORF reveals why such events do not generally occur in mammalian mRNA translation. Genes Dev. 2007, 21:3149-3162.
175. Proutski V., Gaunt M.W., Gould E.A., Holmes E.C. Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J. Gen. Virol. 1997, 78(Pt 7):1543-1549.
176. Proutski V., Gould E.A., Holmes E.C. Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 1997, 25:1194-1202.
177. Proutski V., Gritsun T.S., Gould E.A., Holmes E.C. Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 1999, 64:107-123.
178. Radford A.D., Coyne K.P., Dawson S., Porter C.J., Gaskell R.M. Feline calicivirus. Vet. Res. 2007, 38:319-335.
179. Radford A.D., Dawson S., Coyne K.P., Porter C.J., Gaskell R.M. The challenge for the next generation of feline calicivirus vaccines. Vet. Microbiol. 2006, 117:14-18.
180. Reuter G., Farkas T., Berke T., Jiang X., Matson D.O., Szucs G. Molecular epidemiology of human calicivirus gastroenteritis outbreaks in Hungary, 1998 to 2000. J. Med. Virol. 2002, 68:390-398.
181. Robel I., Gebhardt J., Mesters J.R., Gorbalenya A., Coutard B., Canard B., Hilgenfeld R., Rohayem J. Functional characterization of the cleavage specificity of the sapovirus chymotrypsin-like protease. J. Virol. 2008, 82:8085-8093.
182. Rockx B.H., Vennema H., Hoebe C.J., Duizer E., Koopmans M.P. Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis. 2005, 191:749-754.
183. Rohayem J., Jager K., Robel I., Scheffler U., Temme A., Rudolph W. Characterization of norovirus 3Dpol RNA-dependent RNA polymerase activity and initiation of RNA synthesis. J. Gen. Virol. 2006, 87:2621-2630.
184. Rohayem J., Munch J., Rethwilm A. Evidence of recombination in the norovirus capsid gene. J. Virol. 2005, 79:4977-4990.
185. Rohayem J., Robel I., Jager K., Scheffler U., Rudolph W. Protein-primed and de novo initiation of RNA synthesis by norovirus 3Dpol. J. Virol. 2006, 80:7060-7069.
186. Rossignol J.F., El-Gohary Y.M. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol. Ther. 2006, 24:1423-1430.
187. Rydell G.E., Nilsson J., Rodriguez-Diaz J., Ruvoen-Clouet N., Svensson L., Le Pendu J., Larson G. Human noroviruses recognize sialyl Lewis×neoglycoprotein. Glycobiology 2009, 19:309-320.
188. Sakuma Y., Chiba S., Kogasaka R., Terashima H., Nakamura S., Horino K., Nakao T. Prevalence of antibody to human calicivirus in general population of northern Japan. J. Med. Virol. 1981, 7:221-225.
189. Scheffler U., Rudolph W., Gebhardt J., Rohayem J. Differential cleavage of the norovirus polyprotein precursor by two active forms of the viral protease. J. Gen. Virol. 2007, 88:2013-2018.
190. Schuffenecker I., Ando T., Thouvenot D., Lina B., Aymard M. Genetic classification of " Sapporo-like viruses" Arch. Virol. 2001, 146:2115-2132.
191. Seah E.L., Marshall J.A., Wright P.J. Open reading frame 1 of the Norwalk-like virus Camberwell: completion of sequence and expression in mammalian cells. J. Virol. 1999, 73:10531-10535.
192. Seah E.L., Marshall J.A., Wright P.J. Trans activity of the norovirus Camberwell proteinase and cleavage of the N-terminal protein encoded by ORF1. J. Virol. 2003, 77:7150-7155.
193. Shirato-Horikoshi H., Ogawa S., Wakita T., Takeda N., Hansman G.S. Binding activity of norovirus and sapovirus to histo-blood group antigens. Arch. Virol. 2006.
194. Siebenga J.J., Beersma M.F., Vennema H., van Biezen P., Hartwig N.J., Koopmans M. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J. Infect. Dis. 2008, 198:994-1001.
195. Simmonds P., Karakasiliotis I., Bailey D., Chaudhry Y., Evans D.J., Goodfellow I.G. Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res. 2008, 36:2530-2546.
196. Simor A.E., McArthur M., McGeer A., Shurtleff S., Jabar M. Calicivirus gastroenteritis in a geriatric long-term care facility-Ontario. Can. Dis. Wkly. Rep. 1990, 16:239-240. 243.
197. Smiley J.R., Chang K.O., Hayes J., Vinje J., Saif L.J. Characterization of an enteropathogenic bovine calicivirus representing a potentially new calicivirus genus. J. Virol. 2002, 76:10089-10098.
198. Smith A.E., Helenius A. How viruses enter animal cells. Science 2004, 304:237-242.
199. Smith A.W., Akers T.G., Madin S.H., Vedros N.A. San Miguel sea lion virus isolation, preliminary characterization and relationship to vesicular exanthema of swine virus. Nature 1973, 244:108-110.
200. Smith A.W., Boyt P.M. Caliciviruses of ocean origin: a review. J. Zoo Wildl. Med. 1990, 21:3-23.
201. Smith A.W., Iversen P.L., O'Hanley P.D., Skilling D.E., Christensen J.R., Weaver S.S., Longley K., Stone M.A., Poet S.E., Matson D.O. Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection. Am. J. Vet. Res. 2008, 69:23-32.
202. Smith A.W., Skilling D.E., Cherry N., Mead J.H., Matson D.O. Calicivirus emergence from ocean reservoirs: zoonotic and interspecies movements. Emerg. Infect. Dis. 1998, 4:13-20.
203. Someya Y., Takeda N., Miyamura T. Identification of active-site amino acid residues in the Chiba virus 3C-like protease. J. Virol. 2002, 76:5949-5958.
204. Sosnovtsev S., Green K.Y. RNA transcripts derived from a cloned full-length copy of the feline calicivirus genome do not require VpG for infectivity. Virology 1995, 210:383-390.
205. Sosnovtsev S.V., Belliot G., Chang K.O., Onwudiwe O., Green K.Y. Feline calicivirus VP2 is essential for the production of infectious virions. J. Virol. 2005, 79:4012-4024.
206. Sosnovtsev S.V., Belliot G., Chang K.O., Prikhodko V.G., Thackray L.B., Wobus C.E., Karst S.M., Virgin H.W., Green K.Y. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 2006, 80:7816-7831.
207. Sosnovtsev S.V., Garfield M., Green K.Y. Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J. Virol. 2002, 76:7060-7072.
208. Sosnovtsev S.V., Green K.Y. Identification and genomic mapping of the ORF3 and VPg proteins in feline calicivirus virions. Virology 2000, 277:193-203.
209. Sosnovtsev S.V., Prikhod'ko E.A., Belliot G., Cohen J.I., Green K.Y. Feline calicivirus replication induces apoptosis in cultured cells. Virus Res. 2003, 94:1-10.
210. Sosnovtsev S.V., Sosnovtseva S.A., Green K.Y. Cleavage of the feline calicivirus capsid precursor is mediated by a virus-encoded proteinase. J. Virol. 1998, 72:3051-3059.
211. Sosnovtseva S.A., Sosnovtsev S.V., Green K.Y. Mapping of the feline calicivirus proteinase responsible for autocatalytic processing of the nonstructural polyprotein and identification of a stable proteinase-polymerase precursor protein. J. Virol. 1999, 73:6626-6633.
212. Stein D.A. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers. Curr. Pharm. Des. 2008, 14:2619-2634.
213. Stein D.A., Huang C.Y., Silengo S., Amantana A., Crumley S., Blouch R.E., Iversen P.L., Kinney R.M. Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. J. Antimicrob. Chemother. 2008, 62:555-565.
214. Stein D.A., Shi P.Y. Nucleic acid-based inhibition of flavivirus infections. Front. Biosci. 2008, 13:1385-1395.
215. Straub T.M., Honer zu Bentrup K., Orosz-Coghlan P., Dohnalkova A., Mayer B.K., Bartholomew R.A., Valdez C.O., Bruckner-Lea C.J., Gerba C.P., Abbaszadegan M., Nickerson C.A. In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. Dis. 2007, 13:396-403.
216. Stuart A.D., Brown T.D. Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes. J. Virol. 2006, 80:7500-7509.
217. Swofford D.L. PAUP, Phylogenetic Analysis Using Parsimony (and other methods) 2002, Sinauer Associates, Sunderland.
218. Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Levine M.M., Arntzen C.J. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 2000, 182:302-305.
219. Tamura M., Natori K., Kobayashi M., Miyamura T., Takeda N. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J. Virol. 2004, 78:3817-3826.
220. Tan, M., Xia, M., Chen, Y., Bu, W., Hegde, R.S., Meller, J., Li, X., Jiang, X., 2009. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4, e5058 (Epub 2009 Apr 1).
221. Tan M., Huang P., Meller J., Zhong W., Farkas T., Jiang X. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J. Virol. 2003, 77:12562-12571.
222. Taube S., Kurth A., Schreier E. Generation of recombinant norovirus-like particles (VLP) in the human endothelial kidney cell line 293T. Arch. Virol. 2005, 150:1425-1431.
223. Taube S., Perry J.W., Yetming K., Patel S.P., Auble H., Shu L., Nawar H.F., Lee C.H., Connell T.D., Shayman J.A., Wobus C.E. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 2009, 83:4092-4101.
224. Teunis P.F., Moe C.L., Liu P., Miller S.E., Lindesmith L., Baric R.S., Le Pendu J., Calderon R.L. Norwalk virus: how infectious is it?. J. Med. Virol. 2008, 80:1468-1476.
225. Thackray L.B., Wobus C.E., Chachu K.A., Liu B., Alegre E.R., Henderson K.S., Kelley S.T., Virgin H.W.t. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 2007, 81:10460-10473.
226. Thumfart J.O., Meyers G. Feline calicivirus: recovery of wild-type and recombinant viruses after transfection of cRNA or cDNA constructs. J. Virol. 2002, 76:6398-6407.
227. Tompkins S.M., Lo C.Y., Tumpey T.M., Epstein S.L. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8682-8686.
228. Treiber D.K., Williamson J.R. Beyond kinetic traps in RNA folding. Curr. Opin. Struct. Biol. 2001, 11:309-314.
229. Tsukiyama-Kohara K., Iizuka N., Kohara M., Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 1992, 66:1476-1483.
230. Vinje J., Green J., Lewis D.C., Gallimore C.I., Brown D.W., Koopmans M.P. Genetic polymorphism across regions of the three open reading frames of " Norwalk-like viruses" Arch. Virol. 2000, 145:223-241.
231. von Eije K.J., ter Brake O., Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 2008, 82:2895-2903.
232. Wang C., Sarnow P., Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 1993, 67:3338-3344.
233. Wang Q.H., Costantini V., Saif L.J. Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology. Vaccine 2007, 25:5453-5466.
234. Wang Q.H., Han M.G., Cheetham S., Souza M., Funk J.A., Saif L.J. Porcine noroviruses related to human noroviruses. Emerg. Infect. Dis. 2005, 11:1874-1881.
235. Ward V.K., McCormick C.J., Clarke I.N., Salim O., Wobus C.E., Thackray L.B., Virgin H.W.t., Lambden P.R. Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11050-11055.
236. Widdowson M.A., Monroe S.S., Glass R.I. Are noroviruses emerging?. Emerg. Infect. Dis. 2005, 11:735-737.
237. Wilhelmi I., Roman E., Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin. Microbiol. Infect. 2003, 9:247-262.
238. Wobus C.E., Karst S.M., Thackray L.B., Chang K.O., Sosnovtsev S.V., Belliot G., Krug A., Mackenzie J.M., Green K.Y., Virgin H.W. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2004, 2:e432.
239. Wobus C.E., Thackray L.B., Virgin H.W.t. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 2006, 80:5104-5112.
240. Wyatt R.G., Dolin R., Blacklow N.R., DuPont H.L., Buscho R.F., Thornhill T.S., Kapikian A.Z., Chanock R.M. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 1974, 129:709-714.
241. Xiang W., Harris K.S., Alexander L., Wimmer E. Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J. Virol. 1995, 69:3658-3667.
242. Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H., Gao G.F., Anand K., Bartlam M., Hilgenfeld R., Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13190-13195.
243. Zakhour, M., Ruvoën-Clouet, N., Charpilienne, A., Langpap, B., Poncet, D., Peters, T., Bovin, N., Le Pendu, J., 2009. The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission. PLoS Pathog 5 (Epub Jul 3).
244. Zeitler C.E., Estes M.K., Venkataram Prasad B.V. X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J. Virol. 2006, 80:5050-5058.
245. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., Behera S., Singam R., Lockey R.F., Mohapatra S.S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 2005, 11:56-62.
246. Zhang Y., Yao Q., Xia C., Jiang X., Wang P.G. Trapping norovirus by glycosylated hydrogels: a potential oral antiviral drug. ChemMedChem 2006, 1:1361-1366.
247. Zheng D.P., Ando T., Fankhauser R.L., Beard R.S., Glass R.I., Monroe S.S. Norovirus classification and proposed strain nomenclature. Virology 2006, 346:312-323.